A detailed history of Hbw Advisory Services LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Hbw Advisory Services LLC holds 7,214 shares of ABBV stock, worth $1.29 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
7,214
Previous 7,852 8.13%
Holding current value
$1.29 Million
Previous $1.35 Million 5.79%
% of portfolio
0.23%
Previous 0.24%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

SELL
$163.84 - $199.33 $104,529 - $127,172
-638 Reduced 8.13%
7,214 $1.42 Million
Q2 2024

Jul 05, 2024

SELL
$154.79 - $180.76 $117,795 - $137,558
-761 Reduced 8.84%
7,852 $1.35 Million
Q4 2023

Jan 16, 2024

SELL
$137.6 - $154.97 $183,833 - $207,039
-1,336 Reduced 13.43%
8,613 $1.34 Million
Q3 2023

Oct 11, 2023

SELL
$133.59 - $154.65 $270,653 - $313,320
-2,026 Reduced 16.92%
9,949 $1.48 Million
Q2 2023

Jul 05, 2023

BUY
$132.51 - $164.9 $185,514 - $230,860
1,400 Added 13.24%
11,975 $1.61 Million
Q1 2023

Apr 07, 2023

SELL
$144.61 - $166.54 $449,303 - $517,439
-3,107 Reduced 22.71%
10,575 $1.69 Million
Q3 2022

Oct 05, 2022

SELL
$134.21 - $153.93 $7,515 - $8,620
-56 Reduced 0.41%
13,682 $1.84 Million
Q2 2022

Jul 13, 2022

BUY
$137.62 - $174.96 $606,353 - $770,873
4,406 Added 47.21%
13,738 $2.11 Million
Q1 2022

Apr 18, 2022

SELL
$131.98 - $163.75 $26,395 - $32,750
-200 Reduced 2.1%
9,332 $1.51 Million
Q4 2021

Jan 11, 2022

SELL
$107.43 - $135.93 $3.92 Million - $4.96 Million
-36,515 Reduced 79.3%
9,532 $1.29 Million
Q3 2021

Oct 08, 2021

SELL
$106.4 - $120.78 $38,197 - $43,360
-359 Reduced 0.77%
46,047 $4.97 Million
Q2 2021

Jul 15, 2021

BUY
$105.21 - $117.21 $389,803 - $434,263
3,705 Added 8.68%
46,406 $5.23 Million
Q1 2021

Apr 13, 2021

BUY
$102.3 - $112.62 $274,573 - $302,272
2,684 Added 6.71%
42,701 $4.62 Million
Q4 2020

Jan 12, 2021

BUY
$80.49 - $108.67 $222,474 - $300,363
2,764 Added 7.42%
40,017 $4.29 Million
Q3 2020

Oct 14, 2020

BUY
$85.91 - $100.83 $605,751 - $710,952
7,051 Added 23.35%
37,253 $3.26 Million
Q2 2020

Jul 08, 2020

BUY
$73.37 - $98.18 $151,068 - $202,152
2,059 Added 7.32%
30,202 $2.97 Million
Q1 2020

Apr 30, 2020

BUY
$64.5 - $97.79 $115,326 - $174,848
1,788 Added 6.78%
28,143 $2.16 Million
Q4 2019

Jan 16, 2020

BUY
$72.13 - $90.25 $144,260 - $180,500
2,000 Added 8.21%
26,355 $2.34 Million
Q3 2019

Oct 11, 2019

BUY
$62.98 - $75.72 $1.53 Million - $1.84 Million
24,355 New
24,355 $1.84 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Hbw Advisory Services LLC Portfolio

Follow Hbw Advisory Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hbw Advisory Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hbw Advisory Services LLC with notifications on news.